International Immunology, Vol. 11, No. 11, 1763-1773,
November 1999
© 1999 Japanese Society for Immunology
Protective immune correlates can segregate by vaccine type in a murine herpes model system
Department of Pathology and Laboratory Medicine, 505 Stellar-Chance Lab, University of Pennsylvania, 422 Curie Drive, Philadelphia, PA 19104, USA
1 WLV, Malvern, PA 19355, USA
Correspondence to: D. B. Weiner
A central tenet of vaccine development is to identify immune correlates of protection. Both plasmid-encoded gD as well as recombinant protein gD can protect mice from lethal herpes simplex virus (HSV) challenge. It is known that different vaccine modalities should induce different immune phenotypes. Yet, paradoxically, it is also thought that the basis for protection should rely on exploitation of vulnerabilities of the pathogen and therefore that the overlapping properties of these different vaccines would reveal insight into common immune mechanisms responsible for protection. We sought to investigate this question by comparing two different vaccine modalities in the HSV-2 mouse model. We observed that gD protein was a strong inducer of Th2-type immune responses, and overall antibody titers of IgG, IgE and IgA were significantly higher than those induced by plasmid gD vaccines. In contrast, the plasmid gD vaccine induced a strong Th1 bias. Following high-dose challenge the gD protein was most effective at providing protection. However, at lower lethal dose challenge, while both vaccines were protective with regards to survival, only the plasmid-vaccinated animals were protected from HSV-2 infection-induced morbidity. These studies suggest that these different vaccine modalities induce protection through unique non-overlapping mechanisms, supporting that vaccine correlates are associated with the types of immunogen rather than solely the pathogen.
Keywords: DNA vaccine, herpes simplex virus infection, protective correlates, subunit vaccine, Th1, Th2
Transmitting editor: M. Feldmann
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Hoshino, S. K. Dalai, K. Wang, L. Pesnicak, T. Y. Lau, D. M. Knipe, J. I. Cohen, and S. E. Straus Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs J. Virol., January 1, 2005; 79(1): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. BenMohamed, G. Bertrand, C. D. McNamara, H. Gras-Masse, J. Hammer, S. L. Wechsler, and A. B. Nesburn Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity J. Virol., September 1, 2003; 77(17): 9463 - 9473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Shedlock and D. B. Weiner DNA vaccination: antigen presentation and the induction of immunity J. Leukoc. Biol., December 1, 2000; 68(6): 793 - 806. [Abstract] [Full Text]
|
|
|
|
|
|
J.-I. Sin, J. J. Kim, C. Pachuk, C. Satishchandran, and D. B. Weiner DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo J. Virol., December 1, 2000; 74(23): 11173 - 11180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Sin, J. Kim, C. Patchuk, and D. B. Weiner Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo Clin. Vaccine Immunol., September 1, 2000; 7(5): 751 - 758. [Abstract] [Full Text] [PDF]
|
|